Clinical trial
Lenalidomide in Previously Treated Patients With Chronic Lymphocytic…
NCT00439231 · Georg Aue, M.D., NIH · Completed
Key facts
| NCT number | NCT00439231 |
|---|---|
| Title | Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
| Official title | A Phase II Study of Lenalidomide Revlimid(Registered Trademark) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
| Lead sponsor | Georg Aue, M.D., NIH |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma |
| Intervention type | Drug |
| Interventions | Lenalidomide |
| Enrollment | 33 |
| Start date | Feb 1, 2007 |
| Primary completion | Sep 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Feb 23, 2007 |
| Last update posted | Jan 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: